Jeffrey L. Wade
2018
Compensation breakdown
| Bonus | $158,450 |
|---|---|
| Option Awards | $520,384 |
| Salary | $436,644 |
| Stock Awards | $280,630 |
| Other | $11,895 |
| Total | $1,408,003 |
Wade received $520.4K in option awards, accounting for 37% of the total pay in 2018.
Wade also received $158.5K in bonus, $436.6K in salary, $280.6K in stock awards and $11.9K in other compensation.
Rankings
In 2018, Jeffrey L. Wade's compensation ranked 7,472nd out of 14,244 executives tracked by ExecPay. In other words, Wade earned more than 47.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,472 out of 14,244 | 48th |
Division Manufacturing | 2,899 out of 5,765 | 50th |
Major group Chemicals And Allied Products | 1,089 out of 2,128 | 49th |
Industry group Drugs | 920 out of 1,817 | 49th |
Industry Pharmaceutical Preparations | 722 out of 1,391 | 48th |
Pay ratio
| Jeffrey L. Wade's Pay | $1,408,003 |
|---|---|
| Median Employee's Pay | $195,778 |
| Pay Ratio | 7to 1 |
In 2018, the annual total compensation of Jeffrey L. Wade was $1,408,003.
The annual total compensation of the median employee at Lexicon Pharmaceuticals was $195,778.
The ratio of Jeffrey L. Wade's pay to the pay of median employee was therefore 7 to one.
Wade's colleagues
We found six more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2018.
2018
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
2018
Praveen Tyle
Lexicon Pharmaceuticals
Executive Vice President, Research and Development
2018
Pablo Lapuerta
Lexicon Pharmaceuticals
Chief Medical Officer
2018
Alexander Santini
Lexicon Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2018
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, Innovation and Chemical Sciences
2018
Brian Crum
Lexicon Pharmaceuticals
General Counsel
News
March 26, 2024
April 8, 2022
March 19, 2021
March 13, 2020
March 14, 2019